Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 – Radiological features and metric markers-Reference-Cited by-同舟云学术

Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 – Radiological features and metric markers

Published:2021-03 Issue: Volume:159 Page:103230
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Le Fèvre Clara,Constans Jean-Marc,Chambrelant Isabelle,Antoni Delphine,Bund Caroline,Leroy-Freschini Benjamin,Schott Roland^ORCID,Cebula Hélène,Noël Georges

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference306 articles.

1. Incidence of tumour progression and pseudoprogression in high-grade gliomas: a systematic review and meta-analysis;Abbasi;Clin. Neuroradiol.,2018

2. Tumour progression or pseudoprogression? A review of post-treatment radiological appearances of glioblastoma;Abdulla;Clin. Radiol.,2015

3. Distinguishing pseudoprogression from true progression by FLAIR volumetric characteristics compared to 45 gy isodose volumes in treated glioblastoma patients;Abel;Int. J. Radiat. Oncol. • Biol. • Phys.,2012

4. Morphologic MRI features, diffusion tensor imaging and radiation dosimetric analysis to differentiate pseudo-progression from early tumor progression;Agarwal;J. Neurooncol.,2013

5. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods;Ahmed;Cancer Manag. Res.,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma;Clinical and Translational Radiation Oncology;2024-11

2. Distinguishing glioblastoma progression from treatment-related changes using DTI directionality growth analysis;Neuroradiology;2024-08-17

3. Imaging and Liquid Biopsy for Distinguishing True Progression From Pseudoprogression in Gliomas, Current Advances and Challenges;Academic Radiology;2024-08

4. Resolving spatial response heterogeneity in glioblastoma;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-05

5. Glioblastoma Pseudoprogression Discrimination Using Multiparametric Magnetic Resonance Imaging, Principal Component Analysis, and Supervised and Unsupervised Machine Learning;World Neurosurgery;2024-03